Raymond James & Associates Boosts Holdings in Genpact Limited (NYSE:G)

Raymond James & Associates boosted its stake in shares of Genpact Limited (NYSE:G - Free Report) by 160.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 275,195 shares of the business services provider's stock after purchasing an additional 169,389 shares during the quarter. Raymond James & Associates owned about 0.15% of Genpact worth $9,552,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in G. Moneta Group Investment Advisors LLC boosted its position in shares of Genpact by 103,311.3% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 4,937,889 shares of the business services provider's stock valued at $228,723,000 after acquiring an additional 4,933,114 shares during the period. Capital International Investors boosted its position in shares of Genpact by 101.8% in the first quarter. Capital International Investors now owns 3,963,229 shares of the business services provider's stock valued at $172,440,000 after acquiring an additional 1,999,617 shares during the period. Norges Bank bought a new stake in shares of Genpact in the fourth quarter valued at about $81,569,000. FMR LLC boosted its position in shares of Genpact by 8.1% in the third quarter. FMR LLC now owns 17,644,694 shares of the business services provider's stock valued at $638,738,000 after acquiring an additional 1,327,435 shares during the period. Finally, Millennium Management LLC boosted its position in shares of Genpact by 416.0% in the fourth quarter. Millennium Management LLC now owns 918,348 shares of the business services provider's stock valued at $42,538,000 after acquiring an additional 740,389 shares during the period. 96.03% of the stock is owned by institutional investors.

Genpact Trading Down 1.0 %

Shares of NYSE:G traded down $0.32 during mid-day trading on Friday, reaching $31.64. 2,278,914 shares of the company's stock were exchanged, compared to its average volume of 1,766,029. The firm has a market capitalization of $5.71 billion, a price-to-earnings ratio of 9.22, a PEG ratio of 1.50 and a beta of 1.07. The business's fifty day moving average price is $34.37 and its 200-day moving average price is $34.63. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.44 and a current ratio of 1.44. Genpact Limited has a twelve month low of $29.41 and a twelve month high of $45.99.

Genpact (NYSE:G - Get Free Report) last released its earnings results on Thursday, February 8th. The business services provider reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.03. The business had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.12 billion. Genpact had a net margin of 14.10% and a return on equity of 23.19%. On average, research analysts predict that Genpact Limited will post 2.7 EPS for the current fiscal year.

Genpact Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Monday, March 11th were paid a $0.153 dividend. This is an increase from Genpact's previous quarterly dividend of $0.14. This represents a $0.61 annualized dividend and a yield of 1.93%. The ex-dividend date was Friday, March 8th. Genpact's payout ratio is 17.78%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on G shares. StockNews.com downgraded shares of Genpact from a "strong-buy" rating to a "buy" rating in a research note on Friday. Mizuho began coverage on shares of Genpact in a research note on Tuesday, January 30th. They issued a "neutral" rating and a $40.00 price objective on the stock. Robert W. Baird reissued a "neutral" rating and issued a $38.00 price objective on shares of Genpact in a research note on Friday, December 15th. Needham & Company LLC reissued a "buy" rating and issued a $40.00 price objective on shares of Genpact in a research note on Friday, February 9th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Genpact from $42.00 to $43.00 and gave the company an "underweight" rating in a research note on Friday, February 9th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $40.11.

Insider Buying and Selling at Genpact

In other Genpact news, SVP Heather White sold 11,450 shares of Genpact stock in a transaction on Monday, January 22nd. The shares were sold at an average price of $36.00, for a total value of $412,200.00. Following the completion of the sale, the senior vice president now directly owns 21,175 shares of the company's stock, valued at $762,300. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 2.80% of the company's stock.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.